BioLargo Inc
OTC:BLGO
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
0.16
0.4
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
BioLargo Inc
BioLargo Inc
Net Issuance of Common Stock
BioLargo Inc
Net Issuance of Common Stock Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Net Issuance of Common Stock | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
BioLargo Inc
OTC:BLGO
|
Net Issuance of Common Stock
$3.5m
|
CAGR 3-Years
-9%
|
CAGR 5-Years
13%
|
CAGR 10-Years
9%
|
|
|
Sherwin-Williams Co
NYSE:SHW
|
Net Issuance of Common Stock
-$1.7B
|
CAGR 3-Years
17%
|
CAGR 5-Years
-19%
|
CAGR 10-Years
-3%
|
|
|
International Flavors & Fragrances Inc
NYSE:IFF
|
Net Issuance of Common Stock
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Dupont De Nemours Inc
NYSE:DD
|
Net Issuance of Common Stock
-$452m
|
CAGR 3-Years
33%
|
CAGR 5-Years
33%
|
CAGR 10-Years
N/A
|
|
|
Ecolab Inc
NYSE:ECL
|
Net Issuance of Common Stock
-$321.6m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
4%
|
CAGR 10-Years
1%
|
|
|
PPG Industries Inc
NYSE:PPG
|
Net Issuance of Common Stock
-$597m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-2%
|
CAGR 10-Years
6%
|
|
BioLargo Inc
Glance View
BioLargo, Inc. engages in the provision of technology solutions for odor and moisture control, disinfection, and water treatment. The company is headquartered in Westminster, California and currently employs 27 full-time employees. The firm invents, develops, and commercializes platform technologies to solve environmental problems like polyfluoroalkyl substances (PFAS) contamination, advanced water and wastewater treatment, industrial odor and volatile organic compounds (VOC) control, air quality control and infection control. The company provides sustainable solutions for a range of industries and applications. The Company’s products include Advanced Oxidation System (AOS), Aqueous Electrostatic Concentrator (AEC), CupriDyne Clean industrial odor control product, Clyraguard Personal Protection Spray, and hand sanitizer. The firm provides its products through its subsidiaries, including ONM Environmental, Inc., BioLargo Water, Inc., BioLargo Water Investment Group, Inc., BioLargo Development Corp., BioLargo Engineering, Science & Technologies, LLC and Clyra Medical Technologies, Inc.
See Also
What is BioLargo Inc's Net Issuance of Common Stock?
Net Issuance of Common Stock
3.5m
USD
Based on the financial report for Sep 30, 2024, BioLargo Inc's Net Issuance of Common Stock amounts to 3.5m USD.
What is BioLargo Inc's Net Issuance of Common Stock growth rate?
Net Issuance of Common Stock CAGR 10Y
9%
Over the last year, the Net Issuance of Common Stock growth was -24%. The average annual Net Issuance of Common Stock growth rates for BioLargo Inc have been -9% over the past three years , 13% over the past five years , and 9% over the past ten years .
You don't have any saved screeners yet
